Universal Health Services Inc
NYSE:UHS

Watchlist Manager
Universal Health Services Inc Logo
Universal Health Services Inc
NYSE:UHS
Watchlist
Price: 223.87 USD 0.57% Market Closed
Market Cap: 14B USD

Universal Health Services Inc
Investor Relations

Universal Health Services Inc. (UHS) stands as a significant player in the healthcare industry, weaving its narrative through the intricate threads of hospital management and behavioral health services. Founded in 1979, UHS has grown into one of the largest hospital management companies in the United States. Its business model is entrenched in operating acute care hospitals, behavioral health facilities, and ambulatory care centers. These comprehensive healthcare services cater to a diverse range of patient needs, positioning UHS as a crucial component of both community healthcare and specialized medical treatment. Financially, the company's revenue streams rely heavily on patient services, including inpatient admissions and outpatient services, creating a robust network of care facilities that drive profitability and growth.

UHS doesn’t merely run hospitals; it actively invests in expanding its reach and improving its service offerings, ensuring it captures a broad market of patients needing both general and specialized medical attention. Through strategic acquisitions and maintaining high standards of care, UHS continues to bolster its operating capabilities. Its behavioral health segment, in particular, highlights the company’s commitment to addressing mental health issues, a growing concern worldwide. By optimizing operational efficiencies and leveraging its extensive infrastructure, UHS ensures continuous improvement in patient care while maintaining profitable operations. The company's bottom line is thus a reflection of its capacity to manage and integrate healthcare services seamlessly across various levels of patient interaction, ensuring sustainability and growth in a competitive industry landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 28, 2025
AI Summary
Q3 2025

EPS Growth: Adjusted net income per share rose 53% year-over-year to $5.69, driven by strong acute care results, behavioral improvement, and supplemental Medicaid benefits.

Revenue Performance: Revenue grew 13.4% year-over-year in Q3, with both acute and behavioral health segments contributing.

Guidance Raised: 2025 adjusted EPS midpoint was increased by 6% to $21.80 per share, reflecting stronger supplemental Medicaid benefits and solid operational results.

Supplemental Medicaid: UHS recognized a $90 million net benefit in Q3 from the District of Columbia, with more to come in Q4; additional pending benefits in Florida and Nevada could add $75–80 million if approved.

Acute Care Margins: Same-facility EBITDA margin in acute care rose 190 basis points to 15.8%, helped by strong revenue growth and expense management.

Outpatient Expansion: The company is accelerating outpatient growth, opening new freestanding emergency departments and behavioral health access points, including the 1,000 branches brand.

Capital Allocation: A new $1.5 billion share repurchase authorization was approved, and excess cash flow will continue to be directed toward buybacks and dividends absent major M&A.

Behavioral Health Outlook: Volume growth in behavioral health is gradually improving, with hiring gains supporting higher capacity and margin stability expected going forward.

Key Financials
Adjusted Net Income Per Share
$5.69
Net Income Per Share
$5.86
Adjusted EPS Guidance (midpoint, 2025)
$21.80 per diluted share
Supplemental Medicaid Net Benefit (Q3)
$90 million
Acute Care Same-Facility EBITDA Margin
15.8%
Operating Cash Flow (First 9 Months 2025)
$1.3 billion
Capital Expenditures (First 9 Months 2025)
$734 million
Share Repurchases (First 9 Months 2025)
3.19 million shares, $566 million total cost
Share Repurchases (Q3 2025)
1.315 million shares
Stock Repurchase Authorization
$1.759 billion total authorized
Available Borrowing Capacity (as of Sep 30, 2025)
$965 million
Supplemental Medicaid Net Benefit (2025 Full Year Projection)
$1.3 billion
Earnings Call Recording
Other Earnings Calls

Management

Mr. Alan B. Miller
Founder & Executive Chairman of the Board
No Bio Available
Mr. Marc D. Miller
CEO, President & Director
No Bio Available
Mr. Steve G. Filton
Executive VP, CFO & Secretary
No Bio Available
Mr. Matthew Jay Peterson
Executive VP & President of Behavioral Health Division
No Bio Available
Mr. Edward H. Sim
Executive VP & President of Acute Care Division
No Bio Available
Mr. Matthew David Klein
Senior VP & General Counsel
No Bio Available
Victor J. Radina
Senior Vice President of Corporate Development
No Bio Available
Ms. Maria Zangardi
Senior VP of Human Resources & Corporate Officer
No Bio Available
Michael S. Nelson
Senior Vice President of Strategic Services
No Bio Available
Jim Clark
Senior Vice President of Finance - Acute Care Division
No Bio Available

Contacts

Address
PENNSYLVANIA
King of Prussia
367 S Gulph Rd
Contacts
+16107683300.0
uhs.com